Recent studies [23,24,25,26,27,28,29] have revealed that AZGP1 could suppress the malignant phenotype in several cancers, including GC, colorectal cancer, prostate cancer, hepatocellular carcinoma, and so on. This evidence concerns the gene AZGP1 and colorectal cancer.